Citigroup Inc. Sells 3,090 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Citigroup Inc. reduced its holdings in Phibro Animal Health Co. (NASDAQ:PAHC) by 13.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,700 shares of the company’s stock after selling 3,090 shares during the quarter. Citigroup Inc.’s holdings in Phibro Animal Health were worth $252,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. GSA Capital Partners LLP grew its position in shares of Phibro Animal Health by 227.0% in the 3rd quarter. GSA Capital Partners LLP now owns 81,647 shares of the company’s stock worth $1,043,000 after buying an additional 56,676 shares during the last quarter. Bridge City Capital LLC grew its position in shares of Phibro Animal Health by 4.6% in the 3rd quarter. Bridge City Capital LLC now owns 107,221 shares of the company’s stock worth $1,369,000 after buying an additional 4,740 shares during the last quarter. Qube Research & Technologies Ltd bought a new stake in shares of Phibro Animal Health in the 3rd quarter worth approximately $34,000. Trexquant Investment LP grew its position in shares of Phibro Animal Health by 143.6% in the 3rd quarter. Trexquant Investment LP now owns 35,872 shares of the company’s stock worth $458,000 after buying an additional 21,147 shares during the last quarter. Finally, Algert Global LLC grew its position in shares of Phibro Animal Health by 29.7% in the 3rd quarter. Algert Global LLC now owns 40,824 shares of the company’s stock worth $521,000 after buying an additional 9,350 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of research analyst reports. BNP Paribas initiated coverage on Phibro Animal Health in a research note on Thursday, December 7th. They issued an “underperform” rating and a $9.00 target price for the company. StockNews.com cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, March 6th.

Phibro Animal Health Trading Up 1.7 %

PAHC opened at $13.06 on Thursday. The stock has a market cap of $528.93 million, a PE ratio of 36.28, a PEG ratio of 4.64 and a beta of 0.75. The company has a quick ratio of 1.60, a current ratio of 3.12 and a debt-to-equity ratio of 1.66. The business has a 50 day moving average of $12.11 and a 200-day moving average of $11.73. Phibro Animal Health Co. has a 52 week low of $9.40 and a 52 week high of $15.98.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 7th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. The company had revenue of $249.90 million during the quarter, compared to analysts’ expectations of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. Equities research analysts predict that Phibro Animal Health Co. will post 1.12 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 3.68%. The ex-dividend date of this dividend was Tuesday, March 5th. Phibro Animal Health’s payout ratio is 133.33%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.